Outcomes Superior With CABG Versus Multivessel PCI
THURSDAY, Jan. 26, 2023 -- Coronary artery bypass grafting (CABG) outcomes are better than multivessel percutaneous coronary intervention (PCI) outcomes for patients with acute coronary syndrome, according to a study presented at the annual meeting... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2023 Category: Pharmaceuticals Source Type: news

Here Are The Best Travel Memberships Of 2023
For Tim Scott, the best travel membership of 2023 is the one he used this year. He started to feel ill when he landed in San Carlos, Mexico, recently. "Turns out, I was having heart issues," he says. An ambulance rushed him to hospital in Sonora's capital, Hermosillo. After an angioplasty, bypass…#sonora #thomasplante #seanharris #costco #departmentofhomelandsecurity #tsa #timscott #covacglobal #globalentry #maine (Source: Reuters: Health)
Source: Reuters: Health - December 17, 2022 Category: Consumer Health News Source Type: news

After Angioplasty, Depression Can Keep Heart Patients From Taking Meds
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - December 13, 2022 Category: Psychiatry Tags: Cardiology, Psychiatry, News, Source Type: news

After Angioplasty, Depression Can Keep Heart Patients From Taking Meds
TUESDAY, Dec. 13, 2022 -- Patients who undergo angioplasty and stenting to open clogged arteries in and around the heart should also be screened for depression, according to a new study. Researchers found that depressed patients were less likely... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 13, 2022 Category: General Medicine Source Type: news

Black Patients Have Worse Percutaneous Coronary Intervention Outcomes
FRIDAY, Dec. 9, 2022 -- Black patients have a higher risk for 90-day readmission and mortality following percutaneous coronary intervention (PCI) than White patients, according to a study published online Nov. 11 in the American Heart... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 9, 2022 Category: Pharmaceuticals Source Type: news

Novel PCI Screening Approach Detects Diffuse CAD Novel PCI Screening Approach Detects Diffuse CAD
Pullback pressure gradient pre-percutaneous coronary intervention can differentiate diffuse and focal coronary artery disease.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2022 Category: Consumer Health News Tags: Cardiology News Source Type: news

Black Patients Fare Worse Than White Patients After Angioplasty, Stents
A new study finds Black adults who undergo a common procedure to open up clogged arteries are readmitted to the hospital more often than their white peers. (Source: WebMD Health)
Source: WebMD Health - November 30, 2022 Category: Consumer Health News Source Type: news

Black Patients Fare Worse Than White Patients After Angioplasty, Stents
WEDNESDAY, Nov. 30, 2022 -- Black adults who undergo a common procedure to open up clogged arteries are readmitted to the hospital more often than their white peers. They ' re also more likely to die in the years after treatment, a new study... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 30, 2022 Category: General Medicine Source Type: news

Bivalirudin Crowned as Better Anticoagulant for Primary PCI in STEMI
(MedPage Today) -- CHICAGO -- Periprocedural anticoagulation with bivalirudin (Angiomax) for a radial-first approach to primary percutaneous coronary intervention (PCI) improved mortality and bleeding risk compared with heparin in the BRIGHT... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 7, 2022 Category: Cardiology Source Type: news

Johnson & Johnson to Acquire Abiomed
New Brunswick, N.J. and Danvers, Mass., November 1, 2022 – Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.00 per share in cash, corresponding to an enterprise value of approximately $16.6 billion which includes cash acquired. Abiomed shareholders will also receive...
Source: Johnson and Johnson - November 1, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

Long-Term Outcomes of PCI, CABG Compared for Multivessel CAD
WEDNESDAY, Oct. 5, 2022 -- For patients with multivessel coronary artery disease, the rates of major adverse cardiac events and safety events do not differ for those receiving percutaneous coronary intervention (PCI) with everolimus-eluting stent or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 5, 2022 Category: Pharmaceuticals Source Type: news

Keeping Plavix After Short DAPT: Bleeding Benefit Emerges a Few Years After PCI
(MedPage Today) -- A shortened course of dual antiplatelet therapy (DAPT) after angioplasty was associated with reduced bleeding, with no significant uptick in ischemic events, over longer follow-up of the SMART-CHOICE trial. Patients undergoing... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 29, 2022 Category: Cardiology Source Type: news

PCI vs CABG: Does Age Inform Choice for Left Main Coronary Artery Disease?
(MedPage Today) -- BOSTON -- Adding fuel to the controversy of revascularization for left main disease, patients had better survival after coronary artery bypass grafting (CABG) surgery than percutaneous coronary intervention (PCI) in an all... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - September 19, 2022 Category: Surgery Source Type: news

PCI Not (Much) Worse Than CABG for Multivessel Disease Long Term
(MedPage Today) -- BOSTON -- For multivessel coronary artery disease, percutaneous coronary intervention (PCI) pulled even, statistically speaking, with surgery for outcomes after a median of nearly 12 years of follow-up in the Korean BEST trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 19, 2022 Category: Cardiology Source Type: news

TCT 2022: SYMPLICITY HTN-3 Trial Data Show Sustained Long-Term Blood Pressure Reductions With Medtronic Renal Denervation Procedure
Subjects who underwent radiofrequency renal denervation (RF RDN) with the first generation Symplicity ™ renal denervation system, had a statistically significant reduction in office and ambulatory blood pressure compared to subjects in the sham control group. The data were presented today as Late-Breaking Clinical Science at the 34th Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation, and published simultaneously in The Lancet. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - September 18, 2022 Category: Cardiology Source Type: news